Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. Reply

N Engl J Med. 2020 Jan 2;382(1):91. doi: 10.1056/NEJMc1915042.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Colitis, Ulcerative*
  • Humans
  • Induction Chemotherapy
  • Maintenance Chemotherapy
  • Ustekinumab*

Substances

  • Ustekinumab